Close this search box.

All Fenway Health & AAC locations and programs will be closed on 6/19 for Juneteenth. We will reopen on 6/20.

Purpose 2 Study

A Gilead study is going to test the effectiveness and safety of an injectable PrEP twice yearly for adults. Transgender women, transgender men and gender nonbinary people over 18 years of age who have sex with partners assigned male at birth may be eligible. Eligible participants will be compensated $50 for the screening visit, which includes a free rapid HIV test, and up to $2,275 for their time in the study.

For more information, please call or text 617.927.6450 or email [email protected]

You can also fill out the eligibility survey and be contacted after –


Translate »